Stocks and Investing Stocks and Investing
Mon, December 5, 2022
Sun, December 4, 2022
Fri, December 2, 2022
Thu, December 1, 2022
Wed, November 30, 2022

Swayampakula Ramakanth Maintained (XFOR) at Strong Buy with Increased Target to $5 on, Nov 30th, 2022


Published on 2024-10-28 00:22:47 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Increased Target from $3.5 to $5 on, Nov 30th, 2022.

Swayampakula, nor any peers, have made any analyst calls on XFOR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30